Oasmia Pharmaceutical AB - ESG Rating & Company Profile powered by AI
This webpage of Oasmia Pharmaceutical AB is assembled by All Street Sevva using cutting edge NLP. If you are employed by Oasmia Pharmaceutical AB and you would like to use your ESG rating, please get in touch. The assessment of Oasmia Pharmaceutical AB leverages data from across the internet as well as from public disclosures by Oasmia Pharmaceutical AB.
Oasmia Pharmaceutical AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 4.0, social score of 6.7 and governance score of 5.7.
5.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 808 | Tilray Inc | 5.6 | High |
| 808 | Y-mAbs Therapeutics Inc | 5.6 | High |
| 835 | Oasmia Pharmaceutical AB | 5.5 | High |
| 835 | Animalcare Group PLC | 5.5 | High |
| 835 | Bafna Pharmaceuticals Ltd | 5.5 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Oasmia Pharmaceutical AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose current and historical energy intensity?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB report the average age of the workforce?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose cybersecurity risks?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB offer flexible work?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB conduct supply chain audits?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Oasmia Pharmaceutical AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose water use targets?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB have careers partnerships with academic institutions?
Sign up for free to unlockDid Oasmia Pharmaceutical AB have a product recall in the last two years?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose incidents of discrimination?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Oasmia Pharmaceutical AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose parental leave metrics?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Oasmia Pharmaceutical AB involved in embryonic stem cell research?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose its waste policy?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB report according to TCFD requirements?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose energy use targets?
Sign up for free to unlockDoes Oasmia Pharmaceutical AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Oasmia Pharmaceutical AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Oasmia Pharmaceutical AB
These potential risks are based on the size, segment and geographies of the company.
Oasmia Pharmaceutical AB (publ) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. It focuses on manufacturing formulations based on cytostatics. The company offers Apealea/Paclical for the treatment of ovarian cancer. Its products portfolio includes Docetaxel micellar, a patented formulation that combines XR-17 with docetaxel that has completed pre-clinical trial for the treatment of prostate cancer; and Cantrixil, which has completed Phase I clinical trial for the treatment of ovarian cancer. The company also provides combination therapies, such as XR-19 for various forms of cancer, including ovarian, first-line breast, prostate, and lung cancer. In addition, its animal health product portfolio includes Paccal Vet, a patented formulation of paclitaxel for the treatment of mammary carcinoma; and Doxophos Vet, a patented formulation of doxorubicin for the treatment of lymphoma. Oasmia Pharmaceutical AB (publ) was incorporated in 1988 and is headquartered in Uppsala, Sweden.